Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Malcolm Walker

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Heart (British Cardiac Society)|November 24, 2012
Thalassaemia major and the heart: a toxic cardiomyopathy tamed?J Malcolm Walker
Indian Heart Journal|August 21, 2017
Cardio-Oncology - A new subspecialty with collaboration at its heartArjun K Ghosh, J Malcolm Walker
British Journal of Hospital Medicine (London, England : 2005)|January 10, 2017
Cardio-oncologyArjun K Ghosh, J Malcolm Walker
Cardio-Oncology (London, England)|February 11, 2025
SGLT2 inhibitors for prevention and management of cancer treatment-related cardiovascular toxicity: a review of potential mechanisms and clinical insightsCarl Simela, J Malcolm Walker, Arjun K Ghosh, et al.
British Journal of Hospital Medicine (London, England : 2005)|September 29, 2020
Cardio-oncology for the general physician: 'old' and 'new' cardiovascular toxicities and how to manage themMichael Mallouppas, J Malcolm Walker, Avirup Guha, et al.
European Heart Journal|November 2, 2010
Peri-procedural myocardial injury during percutaneous coronary intervention: an important target for cardioprotectionGirish Ganesha Babu, J Malcolm Walker, Derek M Yellon, et al.
JACC. Cardiooncology|July 3, 2023
Anthracyclines and Biomarkers of Myocardial Injury: The Effect of Remote Ischemic ConditioningMichael Mallouppas, Robin Chung, Arjun K Ghosh, et al.
Lancet (London, England)|September 21, 2002
Comparison of effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron concentrations and ventricular function in beta-thalassaemiaLisa J Anderson, Beatrix Wonke, Emma Prescott, et al.
JACC. Cardiooncology|August 16, 2021
CAR T Cell Therapy-Related Cardiovascular Outcomes and Management: Systemic Disease or Direct Cardiotoxicity?Arjun K Ghosh, Daniel H Chen, Avirup Guha, et al.
Cardiovascular Drugs and Therapy|February 11, 2017
Anthracycline Chemotherapy and CardiotoxicityJohn V McGowan, Robin Chung, Angshuman Maulik, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Heart (British Cardiac Society)|November 24, 2012
Thalassaemia major and the heart: a toxic cardiomyopathy tamed?J Malcolm Walker
Indian Heart Journal|August 21, 2017
Cardio-Oncology - A new subspecialty with collaboration at its heartArjun K Ghosh, J Malcolm Walker
British Journal of Hospital Medicine (London, England : 2005)|January 10, 2017
Cardio-oncologyArjun K Ghosh, J Malcolm Walker
Cardio-Oncology (London, England)|February 11, 2025
SGLT2 inhibitors for prevention and management of cancer treatment-related cardiovascular toxicity: a review of potential mechanisms and clinical insightsCarl Simela, J Malcolm Walker, Arjun K Ghosh, et al.
British Journal of Hospital Medicine (London, England : 2005)|September 29, 2020
Cardio-oncology for the general physician: 'old' and 'new' cardiovascular toxicities and how to manage themMichael Mallouppas, J Malcolm Walker, Avirup Guha, et al.
European Heart Journal|November 2, 2010
Peri-procedural myocardial injury during percutaneous coronary intervention: an important target for cardioprotectionGirish Ganesha Babu, J Malcolm Walker, Derek M Yellon, et al.
JACC. Cardiooncology|July 3, 2023
Anthracyclines and Biomarkers of Myocardial Injury: The Effect of Remote Ischemic ConditioningMichael Mallouppas, Robin Chung, Arjun K Ghosh, et al.
Lancet (London, England)|September 21, 2002
Comparison of effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron concentrations and ventricular function in beta-thalassaemiaLisa J Anderson, Beatrix Wonke, Emma Prescott, et al.
JACC. Cardiooncology|August 16, 2021
CAR T Cell Therapy-Related Cardiovascular Outcomes and Management: Systemic Disease or Direct Cardiotoxicity?Arjun K Ghosh, Daniel H Chen, Avirup Guha, et al.
Cardiovascular Drugs and Therapy|February 11, 2017
Anthracycline Chemotherapy and CardiotoxicityJohn V McGowan, Robin Chung, Angshuman Maulik, et al.
Pageof 3